Cargando…

Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide

BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Voges, Maike, Schneider, Carola, Sinn, Malte, Hartig, Jörg S., Reimer, Rudolph, Hauber, Joachim, Moelling, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957839/
https://www.ncbi.nlm.nih.gov/pubmed/27450669
http://dx.doi.org/10.1186/s12879-016-1713-x
_version_ 1782444234547134464
author Voges, Maike
Schneider, Carola
Sinn, Malte
Hartig, Jörg S.
Reimer, Rudolph
Hauber, Joachim
Moelling, Karin
author_facet Voges, Maike
Schneider, Carola
Sinn, Malte
Hartig, Jörg S.
Reimer, Rudolph
Hauber, Joachim
Moelling, Karin
author_sort Voges, Maike
collection PubMed
description BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides may significantly reduce sexual HIV transmission in such environments. METHODS: Here, we investigated structural characteristics and the antiviral activity of the polypurine tract (PPT)-specific ODN A, a 54-mer oligodeoxynucleotide (ODN) that has been previously shown to trigger the destruction of viral RNA genomes by prematurely activating the retroviral RNase H. The stability of ODN A and mutants thereof was tested at various storage conditions. Furthermore, antiviral effects of ODN A were analyzed in various tissue culture HIV-1 infection models. Finally, circular dichroism spectroscopy was employed to gain insight into the structure of ODN A. RESULTS: We show here that ODN A is a powerful tool to abolish HIV-1 particle infectivity, as required for a candidate compound in vaginal microbicide applications. We demonstrate that ODN A is not only capable to prematurely activate the retroviral RNase H, but also prevents HIV-1 from entering host cells. ODN A also exhibited extraordinary stability lasting several weeks. Notably, ODN A is biologically active under various storage conditions, as well as in the presence of carboxymethylcellulose CMC (K-Y Jelly), a potential carrier for application as a vaginal microbicide. ODN A’s remarkable thermostability is apparently due to its specific, guanosine-rich sequence. Interestingly, these residues can form G-quadruplexes and may lead to G-based DNA hyperstructures. Importantly, the pronounced antiviral activity of ODN A is maintained in the presence of human semen or semen-derived enhancer of virus infection (SEVI; i.e. amyloid fibrils), both known to enhance HIV infectivity and reduce the efficacy of some antiviral microbicides. CONCLUSIONS: Since ODN A efficiently inactivates HIV-1 and also displays high stability and resistance against semen, it combines unique and promising features for its further development as a vaginal microbicide against HIV.
format Online
Article
Text
id pubmed-4957839
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49578392016-07-26 Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide Voges, Maike Schneider, Carola Sinn, Malte Hartig, Jörg S. Reimer, Rudolph Hauber, Joachim Moelling, Karin BMC Infect Dis Research Article BACKGROUND: HIV is primarily transmitted by sexual intercourse and predominantly infects people in Third World countries. Here an important medical need is self-protection for women, particularly in societies where condoms are not widely accepted. Therefore, availability of antiviral microbicides may significantly reduce sexual HIV transmission in such environments. METHODS: Here, we investigated structural characteristics and the antiviral activity of the polypurine tract (PPT)-specific ODN A, a 54-mer oligodeoxynucleotide (ODN) that has been previously shown to trigger the destruction of viral RNA genomes by prematurely activating the retroviral RNase H. The stability of ODN A and mutants thereof was tested at various storage conditions. Furthermore, antiviral effects of ODN A were analyzed in various tissue culture HIV-1 infection models. Finally, circular dichroism spectroscopy was employed to gain insight into the structure of ODN A. RESULTS: We show here that ODN A is a powerful tool to abolish HIV-1 particle infectivity, as required for a candidate compound in vaginal microbicide applications. We demonstrate that ODN A is not only capable to prematurely activate the retroviral RNase H, but also prevents HIV-1 from entering host cells. ODN A also exhibited extraordinary stability lasting several weeks. Notably, ODN A is biologically active under various storage conditions, as well as in the presence of carboxymethylcellulose CMC (K-Y Jelly), a potential carrier for application as a vaginal microbicide. ODN A’s remarkable thermostability is apparently due to its specific, guanosine-rich sequence. Interestingly, these residues can form G-quadruplexes and may lead to G-based DNA hyperstructures. Importantly, the pronounced antiviral activity of ODN A is maintained in the presence of human semen or semen-derived enhancer of virus infection (SEVI; i.e. amyloid fibrils), both known to enhance HIV infectivity and reduce the efficacy of some antiviral microbicides. CONCLUSIONS: Since ODN A efficiently inactivates HIV-1 and also displays high stability and resistance against semen, it combines unique and promising features for its further development as a vaginal microbicide against HIV. BioMed Central 2016-07-22 /pmc/articles/PMC4957839/ /pubmed/27450669 http://dx.doi.org/10.1186/s12879-016-1713-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Voges, Maike
Schneider, Carola
Sinn, Malte
Hartig, Jörg S.
Reimer, Rudolph
Hauber, Joachim
Moelling, Karin
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title_full Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title_fullStr Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title_full_unstemmed Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title_short Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotide
title_sort abolishing hiv-1 infectivity using a polypurine tract-specific g-quadruplex-forming oligonucleotide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957839/
https://www.ncbi.nlm.nih.gov/pubmed/27450669
http://dx.doi.org/10.1186/s12879-016-1713-x
work_keys_str_mv AT vogesmaike abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT schneidercarola abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT sinnmalte abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT hartigjorgs abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT reimerrudolph abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT hauberjoachim abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide
AT moellingkarin abolishinghiv1infectivityusingapolypurinetractspecificgquadruplexformingoligonucleotide